Forbion raises $2.6 billion in largest fundraise to date
Biotech company Forbion announced it has raised $2.6 billion, marking its largest fundraising event ever.
Company secures major funding
Forbion completed a capital raise totaling $2.6 billion according to recent reports. This amount represents the biggest financial injection the privately held company has received so far. The funds will support the firm's ongoing research and development activities in biotechnology.
Industry context emerges
Other biotech firms like Caribou Biosciences are shutting down after failing to secure necessary financing for late-stage trials. Meanwhile, researchers Henri B. Kagan and Kenso Soai received the 2026 Nobel Prize in chemistry. Cerevance also reported positive results from a Phase 3 trial involving its experimental pill solengepras.
Reported by one outlet
Only one outlet has published this. Nothing here has been checked against a second report, so read it as that outlet's account and follow the link below for the original.
Reported by
1 independent outlet. Headline as published. Links open the original report.